At NeoVentures Biotechnology Europe we are committed to revolutionizing the biopharmaceutical field through a cutting-edge biomarker discovery platform, propelling the industry towards personalized medicine with rapid, cost-effective, and automated processes for biomarker discovery and validation. Our Aptamarker platform leverages a library of 16.8 million DNA aptamers to analyze epitope profiles in biofluids, liquid biopsy or tissue, facilitating the precise measurement of surrogate biomarkers and expediting the creation of predictive In Vitro Diagnostic (IVD) tests tailored to distinct pathophysiological conditions. With our advanced DNA aptamer libraries and machine learning algorithms, we meticulously screen an extensive array of 16.8 million DNA aptamer-epitope interactions, uncovering intricate molecular complexities, including proteins and macromolecular complexes. Collaborating with us means embarking on projects to identify or validate biomarkers tailored to your specific needs, whether it's predicting side effects in therapeutic treatments, assessing treatment responses, stratifying patients within a pathology on a molecular level (canonical or non-canonical forms of proteins), or mapping target engagement. The Aptamarkers identified through our collaboration will be readily available to you for further commercial development in a qPCR format. Join us in leading high-plex proteomics innovation to shape the future of clinical diagnostic applications.
Company Details
- Employees
- 4
- Founded
- -
- Address
- 1 Mail Du Professeur Georges Mathé, Villejuif,94800,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- neoneuro-aptamers.com
- Keywords
- biotechnology, Alzheimer's, biomarkers, blood diagnosis, pathology detection, aptamers, proteomics.
- HQ
- Villejuif
Neoventures Biotechnology Europe Questions
Neoventures Biotechnology Europe's website is neoneuro-aptamers.com
Neoventures Biotechnology Europe's LinkedIn profile is https://fr.linkedin.com/company/neoventuresbiotecheurope
Neoventures Biotechnology Europe has
4 employees.
View email and phone details for 4
employees at Neoventures Biotechnology Europe.
Neoventures Biotechnology Europe's industry is
Biotechnology Research
Neoventures Biotechnology Europe's top competitors are
Stilla Technologies,
Neoventures,
Nanobiotix,
Alderaan Biotechnology,
Diaorigin Biotechnology,
Mb3 Biostatistics,
Villejuif Bio Park,
Aptamers- Neoventures Biotechnology Inc.,
Ilof,
Htl Biotechnology.
Neoventures Biotechnology Europe's categories are Biotechnology Research
Neoventures Biotechnology Europe's founding year is 2015
